衰老关键蛋白1(FBLN1)重组蛋白
Recombinant Fibulin 1 (FBLN1)
- 编号RPC472Ra02
- 物种Rattus norvegicus (Rat，大鼠) 相同的名称，不同的物种。
- 来源原核表达
- 宿主E.coli
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位分泌, 细胞外基质
- 预测分子量42.9kDa
- 实际分子量44kDa(差异分析请参阅说明书)
- 片段与标签Glu127~Arg243 with N-terminal His and GST Tag
- 缓冲液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性状冻干粉
- 纯度> 90%
- 等电点5.5
-
应用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，请参见活性蛋白。 - 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 1046 ¥ 2616 ¥ 5232 ¥ 15696 ¥ 39240
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
-
产品包装(模拟)
-
产品包装(模拟)
-
SDS-PAGE图
-
通过ISO 9001、ISO 13485质量体系认证
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月，-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
增值服务
相关产品
| 编号 | 适用物种：Rattus norvegicus (Rat，大鼠) | 应用(仅供研究使用，不用于临床诊断！) |
| RPC472Ra02 | 衰老关键蛋白1(FBLN1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPC472Ra01 | 衰老关键蛋白1(FBLN1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAC472Ra01 | 衰老关键蛋白1(FBLN1)多克隆抗体 | WB; IHC; ICC; IP. |
| PAC472Ra02 | 衰老关键蛋白1(FBLN1)多克隆抗体 | WB; IHC; ICC; IP. |
| LAC472Ra71 | 衰老关键蛋白1(FBLN1)多克隆抗体(生物素标记) | WB; IHC; ICC. |
| MAC472Ra22 | 衰老关键蛋白1(FBLN1)单克隆抗体 | WB; IHC; ICC; IP. |
| MAC472Ra23 | 衰老关键蛋白1(FBLN1)单克隆抗体 | WB; IHC; ICC; IP. |
| MAC472Ra21 | 衰老关键蛋白1(FBLN1)单克隆抗体 | WB; IHC; ICC; IP. |
| LAC472Ra72 | 衰老关键蛋白1(FBLN1)单克隆抗体(生物素标记) | WB; IHC; ICC. |
| SEC472Ra | 衰老关键蛋白1(FBLN1)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMC472Ra | 衰老关键蛋白1(FBLN1)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
| PSC472Ra01 | 衰老关键蛋白1(FBLN1)抗体对 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| KSC472Ra01 | 衰老关键蛋白1(FBLN1)检测试剂盒DIY材料(酶联免疫吸附试验法) | Main materials for "Do It (ELISA Kit) Yourself". |
参考文献
| 杂志 | 参考文献 |
| Clin Exp Metastasis. | Augmented expression of urokinase plasminogen activator and extracellular matrix proteins associates with multiple myeloma progression [Pubmed:24807734] |
| Proteomics Clinical Applications | Comparative mass spectrometric and immunoassay‐based proteome analysis in serum of Duchenne muscular dystrophy patients [Pubmed:26680509] |
| PROTEOMICS - Clinical Applications | Comparative mass spectrometric and immunoassay-based proteome analysis in serum ofDuchenne muscular dystrophy patients. [pubmed:26680509] |
| ENVIRONMENTAL RESEARCH | Exploration of identifying novel serum biomarkers for malignant mesothelioma using iTRAQ combined with 2D-LC-MS/MS [Pubmed: 33197421] |
留言咨询
